• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源与食蟹猴皮肤外分泌汗腺中二肽基肽酶 IV 的差异表达。

Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands.

机构信息

Department of Preclinical Safety, Novartis Institutes for Biomedical Research, Klybeckstrasse 141, 4057, Basel, Switzerland.

出版信息

J Mol Histol. 2013 Dec;44(6):733-47. doi: 10.1007/s10735-013-9524-5. Epub 2013 Jul 24.

DOI:10.1007/s10735-013-9524-5
PMID:23880984
Abstract

Dipeptidyl peptidase IV (DPP4) is a peptidase whose inhibition is beneficial in Type II diabetes treatment. Several evidences suggest potential implication of DPP4 in skin disorders such as psoriasis, keloids and fibrotic skin diseases where its inhibition could also be beneficial. DPP4 expression in human skin was described mainly in dermal fibroblasts and a subset of keratinocytes in the basal layer. Of importance in the perspective of preclinical experimentation, DPP4 distribution in skin of non-human primate species has not been documented. This report evidences unexpected differences between a set of human and cynomolgus monkey skin samples revealing a major expression of DPP4 in eccrine sweat glands of cynomolgus monkeys but not in humans. This represents a unique distinctive feature compared to the conserved expression of dipeptidyl peptidases 8 and 9 and potential relevant DPP4 substrates such as neuropeptide Y (NPY) and receptors (NPY-receptor 1 and Neurokinin receptor). Finally the observation that cathepsin D, an unrelated protease, shows the opposite expression compared to DPP4 (present in human but not in cynomolgus monkey eccrine sweat glands) could indicate that human eccrine sweat glands evolved a divergent protease repertoire compared to non-human primates. These unexpected differences in the eccrine sweat glands protease repertoire will need to be confirmed extending the analysis to a major number of donors but could imply possible biochemical divergences, reflecting the functional evolution of the glands and the control of their activity. Our findings also demonstrate that non-human primates studies aiming at understanding DPP4 function in skin biology are not readily translatable to human.

摘要

二肽基肽酶 4(DPP4)是一种肽酶,其抑制作用有益于 2 型糖尿病的治疗。有几项证据表明 DPP4 可能与皮肤疾病有关,如银屑病、瘢痕疙瘩和纤维化皮肤病,其抑制作用也可能有益。DPP4 在人类皮肤中的表达主要在真皮成纤维细胞和基底层的一部分角质形成细胞中。从临床前实验的角度来看,尚未记录非人类灵长类动物皮肤中 DPP4 的分布。本报告证明了一组人类和食蟹猴皮肤样本之间存在出乎意料的差异,揭示了 DPP4 在食蟹猴的外分泌汗腺中大量表达,但在人类中没有表达。与二肽基肽酶 8 和 9 的保守表达以及潜在相关的 DPP4 底物(如神经肽 Y(NPY)和受体(NPY 受体 1 和神经激肽受体)相比,这是一个独特的特征。最后,观察到组织蛋白酶 D,一种不相关的蛋白酶,与 DPP4 的表达相反(存在于人类中,但不存在于食蟹猴的外分泌汗腺中),这表明人类外分泌汗腺与非人类灵长类动物相比进化出了不同的蛋白酶谱。需要通过对更多供体进行分析来确认外分泌汗腺蛋白酶谱中的这些意外差异,但这可能意味着可能存在生化差异,反映了腺体的功能进化和对其活动的控制。我们的发现还表明,旨在了解 DPP4 在皮肤生物学中的功能的非人类灵长类动物研究不易转化为人类。

相似文献

1
Differential expression of dipeptidyl peptidase IV in human versus cynomolgus monkey skin eccrine sweat glands.人源与食蟹猴皮肤外分泌汗腺中二肽基肽酶 IV 的差异表达。
J Mol Histol. 2013 Dec;44(6):733-47. doi: 10.1007/s10735-013-9524-5. Epub 2013 Jul 24.
2
DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.食蟹猴和斯普拉格-道利大鼠组织中DPP8和DPP9的表达
Regul Pept. 2013 Sep 10;186:26-35. doi: 10.1016/j.regpep.2013.07.003. Epub 2013 Jul 12.
3
Vascular origin of vildagliptin-induced skin effects in Cynomolgus monkeys: pathomechanistic role of peripheral sympathetic system and neuropeptide Y.维格列汀在食蟹猴中引起皮肤效应的血管起源:外周交感神经系统和神经肽Y的病理机制作用
Toxicol Pathol. 2014 Jun;42(4):684-95. doi: 10.1177/0192623313516828. Epub 2014 Jan 20.
4
Establishment of a dipeptidyl peptidases (DPP) 8/9 expressing cell model for evaluating the selectivity of DPP4 inhibitors.建立用于评估二肽基肽酶4(DPP4)抑制剂选择性的二肽基肽酶(DPP)8/9表达细胞模型。
J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:8-12. doi: 10.1016/j.vascn.2014.11.002. Epub 2014 Nov 15.
5
Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.二肽基肽酶8和9:与二肽基肽酶IV相比的特异性和分子特征
Biochem J. 2006 Jun 1;396(2):391-9. doi: 10.1042/BJ20060079.
6
Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.人脑膜瘤中二肽基肽酶-IV 活性和/或结构同源物的表达。
Int J Oncol. 2010 Feb;36(2):351-8.
7
Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.沙格列汀对二肽基肽酶4(DPP4)的效力、选择性及长效结合作用:与一种快速解离的DPP4抑制剂相比,沙格列汀在体外和体内维持对DPP4的抑制作用。
BMC Pharmacol. 2012 Apr 4;12:2. doi: 10.1186/1471-2210-12-2.
8
Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: possible implications for the hypothalamic neuropeptidergic system.二肽基肽酶 4(DPP4)缺乏可减轻大鼠饮食诱导的肥胖:可能对下丘脑神经肽系统的影响。
Behav Brain Res. 2011 Jan 20;216(2):712-8. doi: 10.1016/j.bbr.2010.09.024. Epub 2010 Sep 29.
9
DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.DPP4基因缺陷的同源近交系大鼠表现出应激反应减弱、恐惧消退改善以及中枢神经肽Y增加。
Psychoneuroendocrinology. 2015 Mar;53:195-206. doi: 10.1016/j.psyneuen.2015.01.007. Epub 2015 Jan 19.
10
Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.深入了解二肽基肽酶 8 和 9 的表达和功能。
Mol Cancer Res. 2013 Dec;11(12):1487-96. doi: 10.1158/1541-7786.MCR-13-0272. Epub 2013 Sep 13.

本文引用的文献

1
Sitagliptin, a dipeptidyl peptidase-IV inhibitor, improves psoriasis.西他列汀,一种二肽基肽酶-4 抑制剂,可改善银屑病。
Dermatology. 2012;224(1):20-1. doi: 10.1159/000333358. Epub 2011 Nov 1.
2
CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.银屑病患者在接受环孢素、依那西普和补骨脂素加紫外线 A 光疗治疗后,血清中 CD26/二肽基肽酶 IV 和腺苷脱氨酶的水平。
Int J Dermatol. 2011 Aug;50(8):948-55. doi: 10.1111/j.1365-4632.2010.04799.x.
3
Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
二肽基肽酶-4 抑制剂治疗 2 型糖尿病。
Pharmacotherapy. 2010 May;30(5):463-84. doi: 10.1592/phco.30.5.463.
4
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?二肽基肽酶抑制剂:炎症性疾病领域的新兴药物类别?
Trends Pharmacol Sci. 2009 Nov;30(11):600-7. doi: 10.1016/j.tips.2009.08.003.
5
The in vivo expression of dipeptidyl peptidases 8 and 9.二肽基肽酶8和9的体内表达
J Histochem Cytochem. 2009 Nov;57(11):1025-40. doi: 10.1369/jhc.2009.953760. Epub 2009 Jul 6.
6
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.银屑病皮肤中的CD26/二肽基肽酶IV:上调及拓扑学变化
Br J Dermatol. 2008 Jun;158(6):1264-72. doi: 10.1111/j.1365-2133.2008.08515.x. Epub 2008 Mar 29.
7
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function.CD26/二肽基肽酶IV在人T细胞活化及功能中的作用
Front Biosci. 2008 Jan 1;13:2299-310. doi: 10.2741/2844.
8
Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.二肽基肽酶IV样活性抑制剂在正常和瘢痕疙瘩来源的皮肤成纤维细胞中介导抗纤维化作用。
J Invest Dermatol. 2008 Apr;128(4):855-66. doi: 10.1038/sj.jid.5701104. Epub 2007 Oct 18.
9
Measurement of cytokines in sweat patches and plasma in healthy women: validation in a controlled study.健康女性汗液贴片和血浆中细胞因子的测量:一项对照研究中的验证
J Immunol Methods. 2006 Aug 31;315(1-2):99-109. doi: 10.1016/j.jim.2006.07.011. Epub 2006 Aug 10.
10
Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance.皮肤生物学中的神经肽控制机制:生理及临床意义
J Invest Dermatol. 2006 Sep;126(9):1937-47. doi: 10.1038/sj.jid.5700429.